TINEA-VERSICOLOR - EPIDEMIOLOGIC, CLINICAL, AND THERAPEUTIC ASPECTS

被引：58

作者：

BORELLI, D

JACOBS, PH

NALL, L

机构：

[1] STANFORD UNIV,MED CTR,SCH MED,DEPT DERMATOL,STANFORD,CA 94305

[2] CENT UNIV VENEZUELA,CARACAS,VENEZUELA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 1991年 / 25卷 / 02期

关键词：

D O I：

10.1016/0190-9622(91)70198-B

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Age of the patient, climate, season, and local environmental factors influence the onset and course of tinea versicolor (pityriasis versicolor). A number of effective topical therapies are available. In addition, a single dose of 400 mg of oral ketoconazole eliminates the disease and can be used prophylactically in some cases to prevent recurrence.

引用

页码：300 / 305

页数：6

共 36 条

[1]

[Anonymous], 1982, KETOCONAZOLE MANAGEM

[2]

ARTIS WM, 1985, ORAL THERAPY DERMATO, P72

[3] PITIRIASIS-VERSICOLOR BY MALASSEZIA-OVALIS [J].

BORELLI, D .

MYCOPATHOLOGIA, 1985, 89 (03) :147-153

[4]

Borelli D., 1985, Oral therapy in dermatomycoses: a step forward, P111

[5]

BORELLI D, 1980, REV INFECT DIS, V2, P592

[6]

BORELLI D, 1979, REV FUN J M VARGAS, V2, P19

[7]

BORELLI D, 1988, 10 C INT SOC HUM AN

[8]

Borgers M., 1985, Oral therapy in dermatomycoses: a step forward, P51

[9]

Castellani A., 1913, MANUAL TROPICAL MED

[10]

Cauwenbergh G., 1990, Antifungal drug therapy. A complete guide for the practitioner., P297

← 1 2 3 4 →